Please find attached the LOAs for the assignment of clinical trial agreements from PPD to GSK. This assignment will enable PPD to oversee the services under the agreement as well as make payments to the contracted party on behalf of GSK. The letters have been produced by PPD and have the approval of central GSK.
Can you please provide your review of the letters attached and confirm they are OK for Dr Yongyuth to print and sign on behalf of GSK? The date for assignment is 1 October, 2016 so your expedited review is appreciated.